Literature DB >> 21213542

[The effect of fufang zhenzhu tiaozhi capsule on lipid metabolism in atherosclerotic rabbits].

Chun-ping Tang1, Tao Jiang, Jiao Guo, Yan-ping Wei, Chao-yan Yang, Fang-chao Chen.   

Abstract

OBJECTIVE: To observe the effect of fufang zhenzhu tiaozhi capsule (FTZ) on lipid metabolism in atherosclerotic rabbits.
METHODS: 50 rabbits were divided into five groups: normal control group, model group, simvastatin group, the high-dose group and low-dose group of FTZ. The atherosclerotic model was established by feeding the rabbits with high fat diet. The medicine interfered groups were administrated with homologous medicine on the base of high fat diet. All the rabbits were fed for 12 weeks. The blood lipids levels were determined just before the experiment and at the forth, the eighth and the twelfth weekend of the experiment. At the end of the experiment, serum apolipoprotein levels, liver lipid contents and the area of atherosclerotic plaque were determined respectively.
RESULTS: Compared with model group, TC, TG, LDL-C and ApoB levels were significantly decreased in FTZ groups (P < 0.05 or P < 0.01). The level of HDL-C and the ratio of ApoA I /ApoB were raised significantly (P < 0.05). The contents of TC,TG in liver tissue and the area percentage of atherosclerotic plaque were also markedly reduced (P < 0.05 or P < 0.01) in the FTZ groups.
CONCLUSION: FTZ could efficiently regulate the abnormality of lipid metabolism in experimental atherosclerotic rabbits, and this maybe one mamechanisms of its antiatherogenic effect.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21213542

Source DB:  PubMed          Journal:  Zhong Yao Cai        ISSN: 1001-4454


  3 in total

1.  Effects of huogu I formula (I) on correlated factors of bone regeneration in chickens with steroid-induced necrosis of femoral head.

Authors:  Wei-heng Chen; Xiang-ying Kong; Rong Wan; Chun-sheng Xiao; Li Li; Zhi-yao Wang; Na Lin; He-ming Wang
Journal:  Chin J Integr Med       Date:  2012-05-02       Impact factor: 1.978

2.  FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model.

Authors:  Lexun Wang; Huijuan Wu; Yanyue Deng; Shengxi Zhang; Quxing Wei; Qianqian Yang; Shenghua Piao; Weijian Bei; Xianglu Rong; Jiao Guo
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-28       Impact factor: 2.629

3.  NLRP3 Inflammasome Formation and Activation in Nonalcoholic Steatohepatitis: Therapeutic Target for Antimetabolic Syndrome Remedy FTZ.

Authors:  Yu Chen; Xingxiang He; Xinxu Yuan; Jinni Hong; Owais Bhat; Guangbi Li; Pin-Lan Li; Jiao Guo
Journal:  Oxid Med Cell Longev       Date:  2018-07-22       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.